MAITREYA

Maitreya Medicare Share Price

 

 

Start SIP in MAITREYA

Start SIP

Performance

  • Low
  • ₹205
  • High
  • ₹218
  • 52 Week Low
  • ₹192
  • 52 Week High
  • ₹340
  • Open Price₹205
  • Previous Close₹218
  • Volume1,600
  • 50 DMA₹230.65
  • 100 DMA₹241.92
  • 200 DMA₹253.34

Investment Returns

  • Over 1 Month -11.31%
  • Over 3 Month -17.61%
  • Over 6 Month -23.58%
  • Over 1 Year -38.57%

Smart Investing Starts Here Start SIP with Maitreya Medicare for Steady Growth!

Invest Now

Maitreya Medicare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 74.2
  • PEG Ratio
  • -
  • Market Cap Cr
  • 139
  • P/B Ratio
  • 5.2
  • Average True Range
  • 12.03
  • EPS
  • 2.74
  • Dividend Yield
  • 0
  • MACD Signal
  • -8.72
  • RSI
  • 46.97
  • MFI
  • 47.62

Maitreya Medicare Financials

Maitreya Medicare Technicals

EMA & SMA

Current Price
₹205.15
-12.75 (-5.85%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹218.26
  • 50 Day
  • ₹230.65
  • 100 Day
  • ₹241.92
  • 200 Day
  • ₹253.34

Resistance and Support

222.35 Pivot Speed
  • R3 278.40
  • R2 261.20
  • R1 239.55
  • S1 200.70
  • S2 183.50
  • S3 161.85

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Maitreya Medicare Ltd has an operating revenue of Rs. 82.68 Cr. on a trailing 12-month basis. An annual revenue de-growth of -2% needs improvement, Pre-tax margin of 7% is okay, ROE of 7% is fair but needs improvement. The company has a reasonable debt to equity of 14%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. It is currently FORMING a base in its weekly chart and is trading around 25% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 5 which is a POOR score indicating inconsistency in earnings, a RS Rating of 25 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 83 indicates it belongs to a poor industry group of Medical-Hospitals and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Maitreya Medicare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-14 Quarterly Results
2025-05-30 Audited Results
2024-10-28 Quarterly Results
2024-05-28 Audited Results
2024-02-13 Quarterly Results

Maitreya Medicare F&O

Maitreya Medicare Shareholding Pattern

73%
0%
21%
6%

About Maitreya Medicare

  • NSE Symbol
  • MAITREYA
  • BSE Symbol
  • Chairman & Managing Director
  • Dr. Narendra Singh Tanwar
  • ISIN
  • INE0PLQ01011

Similar Stocks to Maitreya Medicare

Maitreya Medicare FAQs

Maitreya Medicare share price is ₹205 As on 16 January, 2026 | 15:18

The Market Cap of Maitreya Medicare is ₹139 Cr As on 16 January, 2026 | 15:18

The P/E ratio of Maitreya Medicare is 74.2 As on 16 January, 2026 | 15:18

The PB ratio of Maitreya Medicare is 5.2 As on 16 January, 2026 | 15:18

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23